Letter from the Director


Jeffrey D. Hasday, M.D.Our mission in the Division of Pulmonary and Critical Care Medicine is to provide compassionate and high quality, cutting edge care for patients with common and unusual pulmonary and critical care diseases , to perform internationally-recognized clinical, translational, and basic research that will further our understanding about mechanisms of disease and lead to improved diagnosis and treatment, and to train the next generation of leaders in pulmonary and critical care medicine.

We have sustained our aggressive growth as a division over the last several years. We have now expanded our asthma research group by adding two additional asthma researchers, Dr. Ray Penn and Dr. Deepak Deshpande.  We have also added 10 additional primary faculty members. Our 29 bed MICU has been open for two years and is going very well. We have doubled the size of our sleep program, initiated programs in pulmonary rehabilitation and mechanical ventilation weaning, and expanded our evidence based and clinical research program with the addition of Drs. Giora Netzer and Avelino Verceles. We have also added key secondary faculty. Dr. Sergei Atamas is an expert in mechanisms of lung fibrosis who discovered the role of the chemokine, PARC, in pulmonary fibrosis. Dr. Teri Franks is the Chairman of Lung and Mediastinal Pathology at the Armed Forces Institute of Pathology and a widely-recognized expert in pathology of interstitial lung diseases, lung cancer, and SARS. Dr. Frank's addition to the Division has catalyzed a strong interaction between us and the AFIP, offering unique training and research opportunities. Dr. Michael Terrin is a pulmonologist and internationally-recognized clinical trialist who has played a leading role in a number of large, paradigm-shifting clinical studies, including the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) Study, the Thrombolysis in Myocardial Infarction (TIMI) Trial, the Multicenter Study of Hydroxyurea in Sickle Cell Anemia (MSH), and the Transfusion Therapy Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair.

Our recent successes include the establishment of programs in Sleep Disorders, Interstitial Lung Disease, Lung Transplantation, the Combined Critical Care Research Center, the Mucosal Biology Research Center, and the Inflammation Research Group. We are one of the founding sites for the NIH ARDSNet (and now ARDSNet-2) and the COPD Clinical Research Network. We have also partnered with our colleagues at Johns Hopkins on a recently awarded NIH Acute Lung Injury SCCOR. We have seen a 25% increase in the size of our fellowship, over a four-fold increase in NIH grant funding, a four-fold increase in our clinical activity, continued 100% pulmonary and critical care boards pass rate for our fellows, and 100% participation by our second and third year fellows in submitting research abstracts for the American Thoracic Society or the American College of Chest Physicians international meetings.

We have established a number of ambitious goals for the division including:

  • recruiting the best and brightest faculty and fellows

  • increase the proportion of our fellows pursuing careers in academic medicine

  • expand our joint training and research programs with AFIP

  • expand our programs in critical care, interstitial lung disease, lung transplantation, pulmonary rehabilitation, and sleep medicine

Our Division enjoys unique resources within the University of Maryland Medical System that make it one of the best places for patients seeking care for common and unusual pulmonary diseases. Additionally, our Division is an outstanding program for MD trainees seeking training in pulmonary/critical care medicine and academic career development, for PhD trainees seeking the highest level postdoctoral research training opportunities, for faculty seeking a supportive environment to perform the highest quality basic, clinical, outcomes, and translational research, and for industrial partners seeking a one-stop shop for preclinical and clinical studies. You can find further information regarding our resources on this website. If you can't find the answers to your questions, don't hesitate to contact me.

Jeffrey D. Hasday, M.D.

This page was last updated: July 26, 2013

         
Average rating (1)